The perception matters, too: If Americans see the vaccine as having been rushed in order to placate Trump, many may refuse to get the shot. Pfizer will not be anywhere near completion of its clinical trial by the end of October, according to a company spokeswoman. Pfizer’s trial blueprints allow the panel to look at the data after just 32 volunteers have become ill with COVID-19. Participants in Pfizer’s trial are given two doses of a vaccine 21 days apart, whereas those in Moderna’s wait 28 days in between. Even as Trump has urged the speedy approval of a vaccine, he has employed harsh rhetoric against the industry.

Source: bd News24 September 30, 2020 12:22 UTC